Bangabandhu Sheikh Mujib Medical University is yet to start the trial of the Gonoshasthaya Kendra-developed COVID-19 testing kit though six days have elapsed after getting permission.
The BSMMU and Gonoshasthaya Kendra officials had several meetings but the process is still stuck at the level of protocol.
Gonoshasthaya founder Zafrullah Chowdhury told New Age that they were yet to hand over their samples as BSMMU doctors were yet to finalise the protocol.
He said that they might handover over a thousand kits for performance trials by next Saturday or Sunday if everything goes accordingly.
BSMMU vice-chancellor Kanak Kanti Barua said that they have formed a committee which was working on it.
The Kendra officials met with the BSMMU committee on Tuesday about the kits’ trial protocol issues.
Gonoshasthaya-RNA Biotech Limited, a concern of Gonoshasthaya Kendra in Bangladesh, had developed Rapid Dot Blot method to test COVID-19.
Though initially the Directorate General of Drug Administration refused to permit the Gonoshasthaya kit, it was allowed for performance trial on Thursday.
Gonoshasthaya preferred BSMMU for the trial, though the sample testing is yet to begin due to various complexities.
A BSMMU official said that they might take some kits from Gonoshasthaya by Sunday and then start the trial.
‘We will test same samples of COVID-19 infected patients using our PCR machine and Gonoshasthaya developed Rapid Dot Blot kit to gauge its efficiency,’ he added.
Want stories like this in your inbox?
Sign up to exclusive daily email
More Stories from Country